ACT 2008 is THE premier international event offering unparalleled networking and knowledge sharing by bringing together the most influential and respected scientists to cover the latest and most promising discoveries surrounding Assay & Screening Advances, GPCR, Protein Kinase, and Ion Channel Drug Targets.

Featuring four comprehensive conference tracks:

This intensive three-day event allows you access to over 75 presentations delivered by respected scientists from both industry and academia, as well as networking opportunities with over 200 professionals in the field.

Opening Keynotes:

	The Challenges of Ion Channel Drug Discovery - Case Studies Greg Kaczorowski, Ph.D., Senior Director, Ion Channel Department, Merck Research Laboratories
	G-Protein Coupled Receptors in 2008: Rethinking What We Thought We Knew Paul A. Insel, M.D., Professor of Pharmacology & Medicine, Director, Medical Scientist Training Program, University of California, San Diego
	Kinase Research 2008: Do We Believe What We See Or Do We See What We Believe? Peter Mueller, Ph.D., CSO & Executive Vice President Drug Innovation and Realization, Vertex Pharmaceuticals, Inc.
	Ushering in the New Era of Opportunistic Gene and Drug Discovery Jeremy Caldwell, Ph.D.,Director of Molecular and Cell Biology, Genomics Institute of the Novartis Research Foundation

Scientific Advisory Board Panel Discussions

• Protein Kinase Targets
  Future of Kinase Inhibitors in Drug Discovery
• Assay & Screening Advances
  Target Centric vs. Systems Biology: Relative Value Development, Tools and Technologies
• G-Protein Coupled Receptors
  Implications of Changing Paradigms in GCPR Signaling on Drug Discovery
• Ion Channel Targets
  Opportunities and Challenges of Ion Channel Drug Discovery